MiniMed To File Home-Use Continuous Glucose Monitor PMA In Early 2000

MiniMed is developing a follow-on version of its continuous glucose monitoring system (CGMS) that will be sold directly to patients, allowing them to monitor their own glucose levels, the firm said following FDA's June 16 approval of a non-consumer configuration as an adjunct to finger-stick blood glucose testing.

More from Archive

More from Medtech Insight